Agenda

TIME

SESSIONS

SPEAKERS

09:30 – 10:00

KEYNOTE SPEAKER

Jim McCormick

President, Ignite International Ltd.

10:00 – 10:30

SESSION 1 – Cannabis Regulatory Intelligence
Medical Cannabis and CBD Products in the UK – Quality, Responsibility, Transparency.
MAIN STAGE

Blair Gibbs
Policy Lead, Centre for Medicinal Cannabis (CMC)

10:30 – 11:00

SESSION 1 – Cannabis Regulatory Intelligence
The European regulatory framework for CBD and appetite amongst European regulators and the banking sector to provide support to the industry
MAIN STAGE

Mark Taylor
Compliance and Regulatory Journalist

11:00 – 11:30

SESSION 1 – Cannabis Regulatory Intelligence
Israel Regulatory Standards Vs European Standards
MAIN STAGE

Golan Bitton
CEO, Univo Pharmaceuticals

11:30 – 12:00

COFFEE BREAK

12:00 – 12:30

SESSION 1 – Cannabis Regulatory Intelligence
Regulatory and Market Intelligence for the CBD Sector
MAIN STAGE

Tim Phillips
Managing Director, CBD Intel

12:30 – 13:15

Panel Discussion
European Regulations, Insights & Opportunities – Where are we now? The Future of Cannabis and CBD

Chaired by Karina Lahnakoski
VP of Quality & Regulatory, Cannabis Compliance Inc.

George McBride
CEO, Hanway Associates

Housam Nasr
COO, London Canna Group

Eveline Van Keymeule
Counsel, Allen & Overy

Blair Gibbs
Policy Lead, Centre for Medicinal Cannabis (CMC)

Hassan Akhtar
Managing Director, CBD Capital

13:15 – 13:45

LUNCH BREAK

13:45 – 14:15

SESSION 2 – Cannabinoid Development Strategies
Investing in Cannabinoids, cultivation, product development, branding and distribution
MAIN STAGE

Patrick Morton
Co-Founder, Cannabis Invest UK

14:15 – 14:45

SESSION 2 – Cannabinoid Development Strategies
Making CBD, Cannabinoids and Medicinal Cannabis affordable: How Emerging Markets will disrupt the global supply chain
MAIN STAGE

Oliver Zugel
Founder and CEO, Foliumed

14:45 – 15:15

SESSION 2 – Cannabinoid Development Strategies
Formulation and product development strategies
MAIN STAGE

Dr Monica Vialpando
Founder, Vialpando LLC

15:15 – 15:45

SESSION 2 – Cannabinoid Development Strategies
Cannabinoids in future dental treatments
MAIN STAGE

Dr. Veronica Stahl, DMD
Director, Principal Clinician, Researcher

15:45 – 16:15

SESSION 3 – The Necessity of Cannabis Testing
Accreditation of Hemp/Cannabis Testing Laboratories
MAIN STAGE

Tracy Szerszon
President, Perry Johnson Lab Accreditation Inc

16:15 – 16:45

SESSION 3 – The Necessity of Cannabis Testing
Determination of CBD and General Cannabinoid Content in Hemp Oils
MAIN STAGE

Dr Richard Hodgson
LC Technical Specialist, Shimadzu

16:45 – 17:15

SESSION 3 – The Necessity of Cannabis Testing
Optimizing Cannabis Testing with Mass Spectrometry
MAIN STAGE

Daniel McMillan
Sr. Manager, SCIEX

17:15 – 17:55

Panel Discussion
Emerging Markets and International Trends – International Insights, Opportunities and Investment
MAIN STAGE

Chaired by David Attwood
Intelligence Arm, Prohibition Partners

Michael Patterson
CEO, US Cannabis Pharmaceutical Research and Development LLC (USA)

Golan Bitton
CEO, Univo Pharmaceuticals (Israel)

Oliver Zugel
Founder and CEO, Foliumed (Columbia)

Costas Vamvakas
Managing Director, VK PREMIUM Business Consultants Ltd. (Greece)

Mait Soosalu
Advance Biotech Laboratories (Sweden AB)

18:00 – 19:30

Drinks Reception
Evening Entertainment
MAIN HALL & NETWORK AREAS

Band
The What if Generation

TIME

SESSIONS

SPEAKERS

10:00 – 10:30

KEYNOTE SPEAKER
Modulation of Neural Networks:
A Glimpse into Cannabis Intelligence

Dr. Zeid Mohamedali
Chief Medical Officer, Zenabis

10:30 – 11:00

SESSION 1 – A Guide to CBD, Cannabinoids and Medical Cannabis
CBD & Cannabinoids for Everyone
MAIN STAGE

Dr Dani Gordon
Doctor, Author, ABIHM, ABIOM

11:00 – 11:30

SESSION 1 – A Guide to CBD, Cannabinoids and Medical Cannabis
Increasing the bioavailability – for better use of cannabinoids
MAIN STAGE

Prof. Ram Reifen
Director, the Research Centre for Nutrigenomics and Functional Foods, Hebrew University of Jerusalem

11:30 – 12:00

SESSION 1 – A Guide to CBD, Cannabinoids and Medical Cannabis
Pure CBD Vs Whole Plant Preparations
MAIN STAGE

Gregor Zorn
Director and Co-Founder, ECTA, European Cannabinoid Therapy Association

12:00 – 12:30

Q&A Session with Dan Bilzerian, Founder, Ignite International, Ltd. & Jim McCormick, President, Ignite International, Ltd

13:00 – 13:30

SESSION 2 – Pre-Clinical/Clinical Studies of Cannabis & Cannabinoids: Concepts, Misconceptions & Evidence
Medical Cannabis – From bench to bedside
MAIN STAGE

Mikael Sodergren
Clinical Lecturer in Surgery, Imperial College London

13:30 – 14:00

SESSION 2 – Pre-Clinical/Clinical Studies of Cannabis & Cannabinoids: Concepts, Misconceptions & Evidence
Haemodynamic effects of Cannabidiol in humans
MAIN STAGE

Dr Saoirse O’sullivan
Professor, University of Nottingham

14:00 – 14:30

SESSION 2 – Pre-Clinical/Clinical Studies of Cannabis & Cannabinoids: Concepts, Misconceptions & Evidence
Research on Cannabis in Cancer
MAIN STAGE

Prof Dr Tamarah Lah Turnšek
Counselor to the Director National Institute of Biology, Slovenia

14:30 – 15:00

KEYNOTE SPEAKER
Medical Cannabis:
What can we do to get more prescriptions?

Prof. Mike Barnes
Chief Medical Officer, European Cannabis Holdings (ECH)

15:00 – 15:45

Panel Discussion
Medical Cannabis Access and Patient Care

Chaired by Prof. Mike Barnes
Chief Medical Officer, ECH, European Cannabis Holdings

Hannah Deacon 
Patient Advocate, End Our Pain

Irit Avisar 
Chairperson, Israeli Medical Cannabis Nurses Association

15:45 – 16:15

SESSION 3 – Pre-Clinical/Clinical Studies of Cannabis & Cannabinoids: Patient Care
Patients in Focus
MAIN STAGE

Irit Avisar
Chairperson, Israeli Medical Cannabis Nurses Association

16:15 – 16:45

SESSION 3 – Pre-Clinical/Clinical Studies of Cannabis & Cannabinoids: Patient Care
Novel synergistic cannabinoid combinations for the treatment of IBS and IBD patients
MAIN STAGE

Zohar Koren Phd
CEO, SciCann Therapeutics Inc.

16:45 – 17:15

SESSION 3 – Pre-Clinical/Clinical Studies of Cannabis & Cannabinoids: Patient Care
Pre-Clinical/Clinical Studies of Cannabis & Cannabinoids: Patient Care
MAIN STAGE

Alex Fraser
Patient Access Specialist, Grow Biotech

17:15 – 17:45

Panel Discussion
Women – The Future of Cannabis
MAIN STAGE

Chaired by Kristina Spionjak
Marketing Director, London Canna Group

Dr Dani Gordon
Doctor, Author, ABIHM, ABIOM

Dr Saoirse O’sullivan
Professor, University of Nottingham

Jasmin Thomas
Founder, Ohana CBD

Joanna Weaver-Pélissier
CEO, BeCann

Róisín Delaney
Editor, Vapouround CBD

Dr Monica Vialpando
Founder, Vialpando LLC

Copyright 2017 Europe CBD Expo. All rights reserved